-
Report details
-
11
Figures
-
4
Tables
-
Market Analysis
-
Overview of IVD Immunoassay
-
Market Outlook
-
Regional Market
-
Top Company Briefs
-
Roche
-
Abbott Diagnostics
-
Siemens Healthineers
-
Other Selected Immunoassay News
-
Executive News Briefing
-
Freenome Raises $254 Million in New Funding
-
QuidelOrtho Axes CEO
-
Agilent CEO to Retire
-
Financial Highlights: Bio-Rad Laboratories and Veracyte
-
Veracyte Reported Strong Performance in 2023
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome
-
DiaSorin Nabs FDA Clearance for New LIAISON PLEX System
-
T2 Biosystems Offers Expanded Panel
-
Cepheid Received FDA Clearance for Xpert Xpress GBS
-
DiaCarta Collaboration to Launch Prostate Cancer LDT
|
In Vitro Diagnostics Business Outlook, Volume 3, Issue 2 - Focus on Immunoassay Overview
21 Mar 2024
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
- Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
Page Count: 34
Table of Contents
-
Market Analysis
-
Overview of IVD Immunoassay
-
Market Outlook
-
Regional Market
-
Top Company Briefs
-
Roche
-
Abbott Diagnostics
-
Siemens Healthineers
-
Other Selected Immunoassay News
-
Executive News Briefing
-
Freenome Raises $254 Million in New Funding
-
QuidelOrtho Axes CEO
-
Agilent CEO to Retire
-
Financial Highlights: Bio-Rad Laboratories and Veracyte
-
Veracyte Reported Strong Performance in 2023
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome
-
DiaSorin Nabs FDA Clearance for New LIAISON PLEX System
-
T2 Biosystems Offers Expanded Panel
-
Cepheid Received FDA Clearance for Xpert Xpress GBS
-
DiaCarta Collaboration to Launch Prostate Cancer LDT
|
More information about this product
Other Users Also Viewed
22 Sep 2023
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro…
30-Country IVD Market Atlas, 2024 (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
22 Mar 2024
|
